DK1028744T3 - Neuronale anvendelser af BMP-11 - Google Patents
Neuronale anvendelser af BMP-11Info
- Publication number
- DK1028744T3 DK1028744T3 DK98957711T DK98957711T DK1028744T3 DK 1028744 T3 DK1028744 T3 DK 1028744T3 DK 98957711 T DK98957711 T DK 98957711T DK 98957711 T DK98957711 T DK 98957711T DK 1028744 T3 DK1028744 T3 DK 1028744T3
- Authority
- DK
- Denmark
- Prior art keywords
- bmp
- proteins
- useful
- disclosed
- neuronal
- Prior art date
Links
- 102100040898 Growth/differentiation factor 11 Human genes 0.000 title abstract 3
- 101710194452 Growth/differentiation factor 11 Proteins 0.000 title abstract 3
- 230000001537 neural effect Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 229940028334 follicle stimulating hormone Drugs 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96629797A | 1997-11-07 | 1997-11-07 | |
| PCT/US1998/023827 WO1999024058A2 (en) | 1997-11-07 | 1998-11-06 | Neuronal uses of bmp-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1028744T3 true DK1028744T3 (da) | 2004-06-21 |
Family
ID=25511184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98957711T DK1028744T3 (da) | 1997-11-07 | 1998-11-06 | Neuronale anvendelser af BMP-11 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1028744B1 (enExample) |
| JP (1) | JP2001522810A (enExample) |
| AT (1) | ATE259652T1 (enExample) |
| AU (2) | AU1276399A (enExample) |
| CA (1) | CA2309538A1 (enExample) |
| DE (1) | DE69821793T2 (enExample) |
| DK (1) | DK1028744T3 (enExample) |
| ES (1) | ES2213927T3 (enExample) |
| PT (1) | PT1028744E (enExample) |
| WO (2) | WO1999024057A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030104977A1 (en) * | 2000-03-31 | 2003-06-05 | Ugo Ripamonti | Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
| TWI329129B (en) | 2001-02-08 | 2010-08-21 | Wyeth Corp | Modified and stabilized gdf propeptides and uses thereof |
| WO2003004527A2 (en) * | 2001-07-06 | 2003-01-16 | Nsgene A/S | Novel neurotrophic factors |
| US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
| IL163525A0 (en) | 2002-02-21 | 2005-12-18 | Wyeth Corp | A follistatin domain containing protein |
| PL374966A1 (en) | 2002-02-21 | 2005-11-14 | Wyeth | Follistatin domain containing proteins |
| US7261893B2 (en) | 2002-10-22 | 2007-08-28 | Wyeth | Neutralizing antibodies against GDF-8 and uses therefor |
| US7591999B2 (en) | 2003-03-04 | 2009-09-22 | Mitsubishi Tanabe Pharma Corporation | Powdery preparation for nasal administration |
| MXPA05012965A (es) | 2003-06-02 | 2006-03-09 | Wyeth Corp | Uso de inhibidores de miostatina (gdf8) en conjuncion con corticoesteroides para el tratamiento de desordenes neuromusculares y composiciones farmaceuticas para ello. |
| US7635760B2 (en) | 2005-10-06 | 2009-12-22 | Eli Lilly And Company | Anti-myostatin antibodies |
| UA92504C2 (en) | 2005-10-12 | 2010-11-10 | Эли Лилли Энд Компани | Anti-myostatin monoclonal antibody |
| UA98308C2 (en) | 2006-09-05 | 2012-05-10 | Эли Лилли Энд Компани | Anti-myostatin antibody |
| WO2014168973A2 (en) | 2013-04-08 | 2014-10-16 | President And Fellows Of Harvard College | Methods and compositions for rejuvenating skeletal muscle stem cells |
| US20160220640A1 (en) * | 2013-06-11 | 2016-08-04 | The Brigham And Women's Hospital, Inc. | Methods and compositions for increasing neurogenesis and angiogenesis |
| WO2015070076A2 (en) * | 2013-11-08 | 2015-05-14 | President And Fellows Of Harvard College | Methods and compositions for rejuvenating neuromuscular junctions |
| EP3949979A1 (en) | 2016-01-06 | 2022-02-09 | President and Fellows of Harvard College | Treatment with gdf11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis |
| WO2019144053A1 (en) * | 2018-01-19 | 2019-07-25 | President And Fellows Of Harward College | Gdf11 variants and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100227406B1 (ko) * | 1993-05-12 | 1999-12-01 | 브루스 엠. 에이센 | Bmp-11 조성물 |
| SE9302550D0 (sv) * | 1993-07-30 | 1993-07-30 | Ernst Hoerlin | Powder inhaler |
| FI960809L (fi) * | 1993-08-26 | 1996-02-22 | Genetics Inst | Hermoregeneraatio käyttäen ihmisen luun morfogeneettisiä proteiineja |
| DK0776337T3 (da) * | 1994-07-08 | 2005-12-12 | Univ Johns Hopkins Med | Vækstdifferentieringsfaktor-11 |
-
1998
- 1998-10-23 WO PCT/US1998/022574 patent/WO1999024057A2/en not_active Ceased
- 1998-10-23 AU AU12763/99A patent/AU1276399A/en not_active Withdrawn
- 1998-11-06 ES ES98957711T patent/ES2213927T3/es not_active Expired - Lifetime
- 1998-11-06 CA CA002309538A patent/CA2309538A1/en not_active Abandoned
- 1998-11-06 DK DK98957711T patent/DK1028744T3/da active
- 1998-11-06 DE DE69821793T patent/DE69821793T2/de not_active Expired - Lifetime
- 1998-11-06 WO PCT/US1998/023827 patent/WO1999024058A2/en not_active Ceased
- 1998-11-06 AT AT98957711T patent/ATE259652T1/de active
- 1998-11-06 AU AU13900/99A patent/AU761940B2/en not_active Ceased
- 1998-11-06 PT PT98957711T patent/PT1028744E/pt unknown
- 1998-11-06 JP JP2000520146A patent/JP2001522810A/ja active Pending
- 1998-11-06 EP EP98957711A patent/EP1028744B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT1028744E (pt) | 2004-06-30 |
| JP2001522810A (ja) | 2001-11-20 |
| DE69821793T2 (de) | 2004-12-30 |
| WO1999024058A2 (en) | 1999-05-20 |
| ES2213927T3 (es) | 2004-09-01 |
| EP1028744A2 (en) | 2000-08-23 |
| WO1999024057A2 (en) | 1999-05-20 |
| AU1276399A (en) | 1999-05-31 |
| EP1028744B1 (en) | 2004-02-18 |
| AU761940B2 (en) | 2003-06-12 |
| ATE259652T1 (de) | 2004-03-15 |
| DE69821793D1 (de) | 2004-03-25 |
| AU1390099A (en) | 1999-05-31 |
| WO1999024058A3 (en) | 1999-08-19 |
| CA2309538A1 (en) | 1999-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT698094E (pt) | Composicoes de bmp-11 | |
| DK1028744T3 (da) | Neuronale anvendelser af BMP-11 | |
| DE69433742D1 (de) | Bmp-10 zusammensetzungen | |
| DE69823046D1 (de) | Praktische in vitro sialylierung von rekombinanten glykpproteinen | |
| DK0429570T3 (da) | Osteoinducerende præparater | |
| ATE328896T1 (de) | Faktor viii vom schwein und hybriden | |
| ATE223486T1 (de) | Bmp-9 zusammensetzungen | |
| DE69726884D1 (de) | Menschliches sdf-5 protein und diesbezügliche zusammensetzungen | |
| DE69013011D1 (de) | Bcrf1-proteine als inhibitoren von interferon-g(g). | |
| ES2170251T3 (es) | (s)-hidroxinitriloliasa de hevea brasiliensis. | |
| GR3033698T3 (en) | Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections. | |
| BR9712767A (pt) | Expressão especìfica para tecido de proteìna de retinoblastoma | |
| ATE349521T1 (de) | Mit cd40 und traf interagierende proteine | |
| SE9604439D0 (sv) | New receptor | |
| DK0925333T3 (da) | Froststabilisering af vandige overtræksmidler med frostbeskyttelsesproteiner |